BioSpace News Archive

The Public Access to SunScreens Coalition, an alliance of public health organizations, physician groups, sunscreen manufacturers and concerned citizens, would like to remind all Americans that sunscreen is a critical tool to reduce risk of melanoma, other skin cancers and premature aging.

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced dosing of the first Alzheimer’s disease patient in the Phase 1b portion of the INVOKE clinical study of AL002.

Former DOJ litigator Jonathan Novak will explain distributor responsibility

For people living with Tourette syndrome and other chronic tic disorders, there are effective treatments that may help improve symptoms, according to a new guideline by the American Academy of Neurology published in the May 7, 2019, online issue of Neurology®, the medical journal of the AAN.

NuVasive, Inc. announced that management will present at the Bank of America Merrill Lynch Healthcare Conference 2019 at the Encore Hotel in Las Vegas on Wednesday, May 15, 2019, at 1:40 p.m. PT/4:40 p.m. ET.

Luminex Corporation announced financial results for the first quarter 2019.

Webcast Available Through Gilead Corporate Website

Hackensack Meridian Health, New Jersey’s largest and most comprehensive and integrated health network, announced the appointments of Sol J. Barer, Ph.D., as chair of the Board of Directors and David S. Perlin, Ph.D., as chief scientific officer at the Hackensack Meridian Health Center for Discovery and Innovation (CDI).

ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX) has been requested by OTC Markets Group to comment on certain recent promotional activity encouraging investors to purchase the Company’s common shares.

TSO3 Inc. (TSX: TOS) (“TSO3" or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for the first quarter ended March 31, 2019.